An IL-13 Inhibitor Blocks the Development of Hepatic Fibrosis During a T-Helper Type 2–dominated Inflammatory Response
Journal of Clinical Investigation - United States
doi 10.1172/jci7325
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 15, 1999
Authors
Publisher
American Society for Clinical Investigation